Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study.

Fonnes T, Trovik J, Edqvist PH, Fasmer KE, Marcickiewicz J, Tingulstad S, Staff AC, Bjørge L, Amant F, Haldorsen IS, Werner H, Akslen LA, Tangen IL, Krakstad C.

BJOG. 2018 Dec;125(13):1695-1703. doi: 10.1111/1471-0528.15403. Epub 2018 Aug 19.

PMID:
29989298
2.

Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study.

Njølstad TS, Werner HM, Marcickiewicz J, Tingulstad S, Staff AC, Oddenes K, Bjørge L, Engh ME, Woie K, Tjugum J, Lode MS, Amant F, Salvesen HB, Trovik J.

PLoS One. 2017 Aug 3;12(8):e0182223. doi: 10.1371/journal.pone.0182223. eCollection 2017.

3.

Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.

Tangen IL, Kopperud RK, Visser NC, Staff AC, Tingulstad S, Marcickiewicz J, Amant F, Bjørge L, Pijnenborg JM, Salvesen HB, Werner HM, Trovik J, Krakstad C.

Br J Cancer. 2017 Sep 5;117(6):840-847. doi: 10.1038/bjc.2017.235. Epub 2017 Jul 27.

4.

Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.

Hagen B, Valla M, Aune G, Ravlo M, Abusland AB, Araya E, Sundset M, Tingulstad S.

Gynecol Oncol. 2016 Dec;143(3):479-483. doi: 10.1016/j.ygyno.2016.10.029. Epub 2016 Oct 21.

PMID:
27776838
5.

Prevalence of human papillomavirus infection among women in rural Nepal.

Shakya S, Syversen U, Åsvold BO, Bofin AM, Aune G, Nordbø SA, Vaidya KM, Karmacharya BM, Afset JE, Tingulstad S.

Acta Obstet Gynecol Scand. 2017 Jan;96(1):29-38. doi: 10.1111/aogs.13036. Epub 2016 Nov 23.

PMID:
27714759
6.

Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.

Hveem TS, Njølstad TS, Nielsen B, Syvertsen RA, Nesheim JA, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, Eraker R, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Werner HM, Bjørge L, Albregtsen F, Liestøl K, Salvesen HB, Trovik J, Danielsen HE; ENITEC network/MoMaTEC study group.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):61-67. doi: 10.1158/1055-9965.EPI-16-0215. Epub 2016 Sep 1.

7.

Community-Based Health Education has Positive Influence on the Attitude to Cervical Cancer Screening among Women in Rural Nepal.

Shakya S, Karmacharya BM, Afset JE, Bofin A, Åsvold BO, Syversen U, Tingulstad S.

J Cancer Educ. 2016 Sep;31(3):547-53. doi: 10.1007/s13187-015-0863-7.

PMID:
26031906
8.

DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.

Njølstad TS, Trovik J, Hveem TS, Kjæreng ML, Kildal W, Pradhan M, Marcickiewicz J, Tingulstad S, Staff AC, Haugland HK, Eraker R, Oddenes K, Rokne JA, Tjugum J, Lode MS; ENITEC Network/MoMaTEC Study Group, Amant F, Werner HM, Salvesen HB, Danielsen HE.

Br J Cancer. 2015 May 12;112(10):1656-64. doi: 10.1038/bjc.2015.123. Epub 2015 Apr 21.

9.

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.

Trovik J, Wik E, Werner HM, Krakstad C, Helland H, Vandenput I, Njolstad TS, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC; MoMaTEC study group, Amant F, Akslen LA, Salvesen HB.

Eur J Cancer. 2013 Nov;49(16):3431-41. doi: 10.1016/j.ejca.2013.06.016. Epub 2013 Aug 8.

10.

A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis.

Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Engh ME, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Salvesen HB.

Eur J Cancer. 2013 Feb;49(3):625-32. doi: 10.1016/j.ejca.2012.09.006. Epub 2012 Oct 1.

PMID:
23036850
11.

Circulating interleukin-8 and plasminogen activator inhibitor-1 are increased in women with ovarian carcinoma.

Aune G, Stunes AK, Lian AM, Reseland JE, Tingulstad S, Torp SH, Syversen U.

Results Immunol. 2012 Nov 2;2:190-5. doi: 10.1016/j.rinim.2012.10.003. eCollection 2012.

12.

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer.

Knappskog S, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC; MoMaTEC study group, Romundstad P, Hveem K, Vatten L, Salvesen HB, Lønning PE.

Eur J Cancer. 2012 Sep;48(13):1988-96. doi: 10.1016/j.ejca.2011.10.024. Epub 2011 Nov 24.

PMID:
22119201
13.

Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.

Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, Salvesen HB; MoMaTEC study group.

Gynecol Oncol. 2012 Apr;125(1):103-8. doi: 10.1016/j.ygyno.2011.11.008. Epub 2011 Nov 17.

PMID:
22100838
14.

Ten years' experience with centralized surgery of ovarian cancer in one health region in Norway.

Aune G, Torp SH, Syversen U, Hagen B, Tingulstad S.

Int J Gynecol Cancer. 2012 Feb;22(2):226-31. doi: 10.1097/IGC.0b013e31823589ef.

PMID:
22080889
15.

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.

Aune G, Stunes AK, Tingulstad S, Salvesen O, Syversen U, Torp SH.

Int J Clin Exp Pathol. 2011 Jun 20;4(5):444-53. Epub 2011 Jun 11.

16.

Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis.

Aune G, Lian AM, Tingulstad S, Torp SH, Forsmo S, Reseland JE, Stunes AK, Syversen U.

Gynecol Oncol. 2011 May 1;121(2):402-6. doi: 10.1016/j.ygyno.2010.12.355. Epub 2011 Feb 1.

PMID:
21284996
17.

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.

Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS; MoMaTec Study Group, Vandenput I, Amant F, Akslen LA, Salvesen HB.

Clin Cancer Res. 2011 May 15;17(10):3368-77. doi: 10.1158/1078-0432.CCR-10-2412. Epub 2011 Jan 17.

18.

The effect of centralization of primary surgery on survival in ovarian cancer patients.

Tingulstad S, Skjeldestad FE, Hagen B.

Obstet Gynecol. 2003 Sep;102(3):499-505.

PMID:
12962932
19.

Survival and prognostic factors in patients with ovarian cancer.

Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B.

Obstet Gynecol. 2003 May;101(5 Pt 1):885-91.

PMID:
12738145
20.

Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway.

Tingulstad S, Halvorsen T, Norstein J, Hagen B, Skjeldestad FE.

Int J Cancer. 2002 Apr 20;98(6):907-11.

21.
22.

A phase II study of biweekly administration of paclitaxel in patients with recurrent epithelial ovarian cancer.

Lorenz E, Hagen B, Himmelmann A, Kjørstad K, Onsrud M, Tingulstad S, Gundersen G.

Int J Gynecol Cancer. 1999 Sep;9(5):373-376.

PMID:
11240796
23.

Primary treatment of cervical carcinoma. Ten years experience from one Norwegian health region.

Hagen B, Skjeldestad FE, Halvorsen T, Strickert T, Tingulstad S, Lorenz E, Onsrud M.

Acta Obstet Gynecol Scand. 2000 Dec;79(12):1093-9.

PMID:
11130094
24.

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.

Hogdall EV, Høgdall CK, Tingulstad S, Hagen B, Nustad K, Xu FJ, Bast RC, Jacobs IJ.

Int J Cancer. 2000 Nov 20;89(6):519-23.

25.

The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals.

Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M.

Obstet Gynecol. 1999 Mar;93(3):448-52.

PMID:
10074998
26.

CO2 laser conization for cervical intraepithelial neoplasia grade II-III: complications and efficacy.

Hagen B, Skjeldestad FE, Bratt H, Tingulstad S, Lie AK.

Acta Obstet Gynecol Scand. 1998 May;77(5):558-63.

PMID:
9654180
27.

Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies.

Syversen U, Opsjøn SL, Stridsberg M, Sandvik AK, Dimaline R, Tingulstad S, Arntzen KJ, Brenna E, Waldum HL.

J Clin Endocrinol Metab. 1996 Dec;81(12):4470-5.

PMID:
8954061
28.

Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses.

Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Nustad K.

Br J Obstet Gynaecol. 1996 Aug;103(8):826-31.

PMID:
8760716
29.

[Preoperative identification of malignancy among women with a pelvic mass. Evaluation of a risk index based on ultrasound findings. CA 125 in serum and menopausal status].

Hagen B, Tingulstad S, Onsrud M, Moen M, Kiserud T, Eik-Nes S, Halvorsen T, Nustad K.

Tidsskr Nor Laegeforen. 1995 Mar 10;115(7):820-2. Norwegian.

PMID:
7701488
30.

[Surgical treatment of cervix cancer. A 6-year material from a regional hospital].

Hagen B, Skjeldestad FE, Tingulstad S, Onsrud M, Halvorsen T.

Tidsskr Nor Laegeforen. 1994 Sep 20;114(22):2603-5. Norwegian.

PMID:
7985176
31.

Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy.

Opsjłn SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R.

Am J Obstet Gynecol. 1993 Aug;169(2 Pt 1):397-404.

PMID:
8362955
32.

[Pelvic joint syndrome as the cause of chronic pelvic pain in women].

Moen MH, Tingulstad S.

Tidsskr Nor Laegeforen. 1991 Feb 28;111(6):690-1. Norwegian.

PMID:
1826182
33.

[Chlamydia trachomatis and ectopic pregnancy. A causal relationship].

Skjeldestad FE, Moen M, Brobak H, Tingulstad S, Dalen A.

Tidsskr Nor Laegeforen. 1989 Aug 30;109(24):2424-6. Norwegian.

PMID:
2814954

Supplemental Content

Loading ...
Support Center